On April 8, 2020, Anyfusin cartridge was passed by the Consumables Committee of Incheon Gil Hospital today. Thank you to the people involved in making efforts to pass the committee even in the COVID-19 situation.

Incheon Gil Hospital is the hospital that conducted clinical trials for normal people in the intensive care unit (ICU) and the first clinical trial for patients in the neonatal intensive care unit (NICU).

As a result of the clinical trial, the lead professor of clinical trial announced the excellence of Anyfusion in the 2019 Korean-Japanese Neonatal Intensive Care Society.

Incheon Gil Hospital is Korea's 5th to 6th largest university hospital in terms of number of beds, and is the representative hospital in Incheon.

We will do our part as a company that leads the business efficiency and A/S (prior service before service (B/S)) to quickly build a smart system as well as safety, effectiveness, and convenience, including new technologies to be developed.

We will do our best to provide quality medicine injection services to users and related people as well as patients.

Thank you.